Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Respond to Prescription Opioid Analgesic Crisis

Larry Beresford  |  Issue: May 2017  |  May 16, 2017

They determined that only 43% of RA patients who were prescribed opiates got that prescription from a rheumatologist. These are Medicare patients, who may have more than one medical problem, Dr. Curtis tells The Rheumatologist. There was also more than fourfold variability in opiate use between rheumatology practices, which the authors attribute to individual prescribing patterns, disease severity and the presence of other painful conditions suffered by patients.

“In sum, our results suggest substantial use of opioids in an older RA population despite societal concerns regarding potential overprescribing in recent years,” Dr. Curtis says. “I’d like to know more about how helpful this is long term.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatology has an important role in complicated pain issues, as the population with rheumatologic condition grows and pain is a common, and often the leading, debilitating problem in these patients, says Perry Fine, MD, professor of anesthesiology at the University of Utah School of Medicine and a national expert in pain treatment.

“Opioids can be either life saving or life threatening, depending on the competence of the prescriber, reliability of the patient and the social sphere in which they reside, and the support systems—formal and informal—available to the patient in creating a safe and effective outcome. At the end of the day, good care requires all of the above, with a focus on patient selection, sound application of prescribing practices and ongoing monitoring of therapeutic effects versus adverse effects and risks,” Dr. Fine concludes in a recent email to The Rheumatologist.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“In other words, we have very few proven high-efficacy options, medical or nonmedical, for long-term management of severe, debilitating intractable pain, and none are risk free. We know from experience and limited literature that some carefully selected and followed patients do benefit from long-term opioid therapy when other approaches have failed,” he says. “In all cases, we must individualize care, taking into account risks of treatment vs. nontreatment, monitor outcomes carefully and closely to minimize risks, especially when using opioids.”

The Place of Interdisciplinary Pain Clinics

“If we have somebody who’s not getting relief at the analgesic doses we are comfortable in providing, do we push the dose until either the pain is relieved or side effects emerge?” Dr. Rapoport poses. “We all get patients in our office who come to the rheumatologist when something hurts. When do we decide to send them to a pain center?” There are too many patients who have chronic pain and need pain management, and they can’t all be sent to a pain center.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:AnalgesicsConditionsDrug UpdatesPain SyndromesPractice Support Tagged with:AddictionanalgesicChronic painepidemicManagementopioidOverdosepatient careprescriptionRheumatic DiseaserheumatologistrheumatologyriskSafetyTreatment

Related Articles

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    10 Tips for Opioid Prescribing

    December 1, 2014

    How to manage the risks when prescribing medications for patients in chronic pain

    urfin / shutterstock.com

    How to Improve Opioid Prescribing in an Outpatient Clinic

    October 18, 2019

    More than 72,000 Americans died from opioid overdoses in 2017, according to the National Institutes of Health.1 The impact of the opioid epidemic has affected many levels of patient care and, as a result, healthcare systems are responding to escalating death rates, new legislation and the possibility of compromised patient safety in a multitude of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences